Ademi LLP is investigating possible securities fraud claims against GeneDx (Nasdaq: WGS). The investigation results from inaccurate statements GeneDx may have made regarding its financial statements, business operations and prospects.
We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Join this Action